- FDA Approves Sarepta Duchenne Drug in Stunning ReversalIn a surprise, the FDA reversed course and approved Sarepta's Duchenne drug. It's not the first time this has happened—and Sarepta stock soared.
- Meet Stephen Hahn, the New FDA CommissionerThe Senate has confirmed MD Anderson's Stephen Hahn as the next FDA commissioner. Here's what you should know.
- The 3 Things That Have Been Holding Back the Fertility BusinessCarrot Fertility CEO Tammy Sun and Modern Fertility chief Afton Vechery discuss what's been holding back the fertility industry—and what the future holds.
- Home Depot Says the Opioid Crisis May Drive Theft. But It's ComplicatedRetail giant Home Depot says that the opioid epidemic may be a factor in store thefts—but it's complicated.
- California Considers Calling THC in Pot a Risk to Moms-to-BeMore than three years after California voters broadly legalized marijuana, a state panel is considering if its potent, high-inducing chemical — THC — should be declared a risk to pregnant women and require warnings.
- Why Sanofi's New CEO Is Trading Diabetes Drugs for Cancer BreakthroughsThe company said it will focus on six promising therapies in areas such as hemophilia, breast cancer, multiple sclerosis and rare diseases.
- How to Prepare for a Brutal 2020 Flu SeasonThe 2020 flu season is here, it's early, and it could be rough. Here's what you should do.
Skip to Content